HCPLive Network
Latest Hospital Medicine Headlines
By W. Todd Penberthy, PhD
The ACC/AHA cholesterol guideline can be a powerful tool for making multifactorial measures of cardiovascular disease risk assessment, particularly in African American populations, but clinicians should be aware of its limitations.
By Desiree Cox, MBBS, PhD
Results from the SAPPHIRE-I trial show that Abbvie’s 3D therapy produced 96% sustained viral response rates at 12 weeks in treatment-naive patient with genotype 1 hepatitis C.
By Desiree Cox, MBBS, PhD
Preliminary results from the M12-999 study show that treatment with ABT-450/ritonavir/ombitasvir plus dasabuvir and ribavirin is well tolerated and associated with high rates of sustained virologic response in adult liver transplant recipients with recurrent HCV genotype 1 infection.
By HCPLive staff
Grastek is the first sublingual allergy immunotherapy product to be approved for use in children as young as age 5.
By W. Todd Penberthy, PhD
Although they offer an alternative to warfarin for preventing stroke in patients with atrial fibrillation, effective use of the new anticoagulants requires careful patient selection.
By Desiree Cox, MBBS, PhD
Results from the phase III ION-2 study show a 24-week regimen of sofosbuvir/ledipasvir does not produce significantly better cure rates than a 12-week regimen in treatment-experienced patients.
By Desiree Cox, MBBS, PhD
Results from the NEED study show combination treatment with peginterferon alpha-2a and either adefovir or entecavir does not increase HBeAg seroconversion rate compared to monotherapy alone in patients with hepatitis B.
By Desiree Cox, MBBS, PhD
Data from the PEARL-I trial of patients with hepatitis C genotype 4 show high rates of sustained virologic response at 12 weeks associated with combination treatment with ABT-450 (a protease inhibitor boosted by ritonavir) and ombitasvir.
By Desiree Cox, MBBS, PhD
An 8-week course of treatment with a fixed dose combination of ledipasvir plus sofosbuvir produced sustained virologic response in more than 90 percent of treatment-naïve patients with genotype 1 hepatitis C.
By Debra Wood, RN
Clinicians should consider a patient’s risk of hypoglycemia, the duration of time with the disease, age, comorbidities, vascular complications, and other factors when setting treatment goals.
Physician's Money Digest
Americans—regardless of age, income, and education—have proven to be pretty awful at handling their personal finances. Given the choice between saving and spending a sudden windfall, they’re more likely to spend the money.
Every time the top US tax rate increases by one percentage point, there is a more than 2% increase in US investors attempting to evade taxes by disguising themselves as foreign investors.
$AD300x250BB$